● COVID-19

  • SARS-CoV-2 influenza A influenza B Nucleic Acid jikọtara

    SARS-CoV-2 influenza A influenza B Nucleic Acid jikọtara

    Ngwa a dabara maka nchọpụta in vitro qualitative nke SARS-CoV-2, influenza A na influenza B nucleic acid nke nasopharyngeal swab na oropharyngeal swab sample nke ndị mmadụ chere na ha bu ọrịa SARS-CoV-2, influenza A na influenza. B.

  • SARS-CoV-2 dị iche iche

    SARS-CoV-2 dị iche iche

    Ezubere ngwa a ka ọ bụrụ nchọpụta qualitative in vitro nke novel coronavirus (SARS-CoV-2) n'ụdị imi nasopharyngeal na oropharyngeal swab.A na-achọpụta RNA sitere na SARS-CoV-2 n'ụdị iku ume n'oge nnukwu ọrịa ma ọ bụ ndị asymptomatic.Enwere ike iji ya n'ihu nchọpụta qualitative na ọdịiche nke Alfa, Beta, Gamma, Delta na Omicron.

  • Ngwa RT-PCR fluorescent ezigbo oge maka ịchọpụta SARS-CoV-2

    Ngwa RT-PCR fluorescent ezigbo oge maka ịchọpụta SARS-CoV-2

    Ezubere ngwa a ka in vitro qualitatively chọpụta ORF1ab na N genes of novel coronavirus (SARS-CoV-2) na nasopharyngeal swab na oropharyngeal swab anakọtara site na ikpe na ụyọkọ ikpe ndị a na-enyo enyo na ọ nwere oyi oyi bu ọrịa coronavirus ọhụrụ na ndị ọzọ achọrọ maka nyocha ahụ. ma ọ bụ nchọpụta dị iche iche nke ọrịa coronavirus ọhụrụ.